AskAt received a notice of allowance dated August 13, 2019 from the Mexican Institute of Industrial Property (IMPI: Instituto Mexicano de la Propiedad Industrial) in connection with the Mexican Patent Application No. MX/a/2016/008394, a use patent of EP4 receptor antagonist for the treatment of cancer.